
R&D expenses of Moderna 2016-2022
The statistic illustrates the research and development expenses of Moderna Inc. between 2016 and 2022. Moderna spent around 3.3 billion U.S. dollars on R&D in 2022, significantly more than in previous years. The company became widely known for being one of two companies worldwide which had their COVID-19 vaccine approved already in late 2020.